NeuroStar® Oral Presentation at AACAP 2024 Highlights Largest Study Evaluating TMS Efficacy in Adolescents with Depression
14. Oktober 2024 08:31 ET
|
Neuronetics
MALVERN, Pa., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Health Care Service Corporation Adds First-Line TMS Coverage for Adolescents
25. September 2024 08:31 ET
|
Neuronetics
MALVERN, Pa., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Expanded Health Policies Enhance TMS Therapy Access for Adolescents and Adults
19. September 2024 08:31 ET
|
Neuronetics
MALVERN, Pa., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
NeuroStar® Releases Software Upgrades to Elevate Patient Care
16. September 2024 08:32 ET
|
Neuronetics
MALVERN, Pa., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
NeuroStar Honors Suicide Prevention Month With Milestone Achievement and Powerful Stories
03. September 2024 08:29 ET
|
Neuronetics
MALVERN, Pa., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
NeuroStar® Marks Two Years of Transformative Impact with NeuroStar University
20. August 2024 08:29 ET
|
Neuronetics
MALVERN, Pa., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
NeuroStar Partners With This Is My Brave to Recognize Teen Mental Health Month
01. August 2024 08:29 ET
|
Neuronetics
MALVERN, Pa., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Aetna Policy Update Expands TMS Availability for Adolescents With Depression
22. Juli 2024 08:31 ET
|
Neuronetics
MALVERN, Pa., July 22, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
California Medicaid Adds TMS Access for 14.8 Million Adolescents and Adults
11. Juli 2024 08:36 ET
|
Neuronetics
MALVERN, Pa., July 11, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
BlueCross BlueShield MI and Cambia Health Solutions Expand TMS Access for Depressed Adolescents
10. Juli 2024 08:32 ET
|
Neuronetics
MALVERN, Pa., July 10, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...